Lirafit 6mg, Liraglutide, Diabetes, Online Pharmacy, ZarvyPharm
DIABETES DIET Cardiovascular Diseases Hypertension Liraglutide LIFESTYLE +3

Lirafit 6mg - 1 Pen

★★★★★
★★★★★
0

(0)

Generic For VICTOZA
Active Ingredient LIRAGLUTIDE
Strength 6MG
Manufacturer GLENMARK
Lirafit 6mg injection pen front box packaging
Lirafit 6mg injection pen side box packaging with label
Lirafit 6mg injection pen front box packaging
Lirafit 6mg injection pen side box packaging with label
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 1 PEN $ 59.00 $ 59.00
$ 50.15
Apply ZARVY26 (-15%)
You save $ 8.85
2 BOXES - 2 PENS $ 53.10
10% $ 118.00
$ 106.20
$ 90.27
Apply ZARVY26 (-15%)
You save $ 15.93
3 BOXES - 3 PENS $ 49.50
16% $ 177.00
$ 148.50
$ 126.23
Apply ZARVY26 (-15%)
You save $ 22.28
★ Best Value 4 BOXES - 4 PENS $ 46.00
22% $ 236.00
$ 184.00
$ 156.40
Apply ZARVY26 (-15%)
You save $ 27.60

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Lirafit 6mg is a GLP-1 receptor agonist developed by Glenmark, primarily used for the treatment of Type 2 diabetes and weight management. Containing Liraglutide 6mg, it mimics incretin hormones, enhancing insulin secretion, suppressing glucagon production, slowing gastric emptying, and reducing appetite. This once-daily injection aids in blood sugar regulation, metabolic health improvement, and cardiovascular risk reduction. It is suitable for adults and children over 10 years old.

Indications & Uses

- Type 2 Diabetes Management: Stimulates insulin release, reduces glucose production, and improves blood sugar control. - Weight Loss & Appetite Suppression: Delays gastric emptying, promotes fullness, and lowers food intake. - Cardiovascular & Metabolic Health: Reduces heart disease risks, lowers cholesterol levels, and improves insulin sensitivity. - Gastrointestinal Benefits: Slows stomach emptying, preventing blood sugar spikes after meals. - Once-Daily Injection for Convenience: Ensures steady blood sugar regulation with long-lasting effects.

Benefits & Effectiveness

Lirafit 6mg contains Liraglutide, a GLP-1 receptor agonist that works by: - Enhancing insulin secretion in response to high blood sugar. - Suppressing glucagon release, preventing excessive glucose production by the liver. - Slowing digestion, leading to improved appetite control and weight loss. - Lowering cardiovascular risks, supporting heart and metabolic health.

Directions for Use

For Diabetes > GLP-1 Receptor Agonists - Lirafit 6mg is a GLP-1 receptor agonist that helps control blood sugar levels in patients with type 2 diabetes. - Starting dose: 0.6mg once daily for the first week, then increase to 1.2mg or 1.8mg as prescribed by your doctor. - Administer subcutaneously once daily in the abdomen, thigh, or upper arm. - Rotate injection sites daily to prevent skin irritation, redness, or lipodystrophy. - Inject at the same time each day, with or without food, for optimal blood sugar regulation. - Do not mix with insulin in the same syringe; if taking insulin, inject separately at different sites. - If nausea, vomiting, or gastrointestinal discomfort occurs, consult a doctor for possible dose adjustments. For Diet > Glycemic Control & Appetite Suppressants - Lirafit 6mg promotes glycemic control by enhancing insulin sensitivity and slowing gastric emptying. - Suppresses appetite, leading to reduced food intake and weight loss in patients managing obesity. - Best results when combined with a balanced diet and regular exercise. - Adequate hydration is important, as appetite suppression may reduce overall fluid intake. - If severe nausea or dehydration occurs, seek medical attention. For Lifestyle-Related Diseases > Cardiovascular Diseases & Hypertension - Proven to reduce cardiovascular risks, including heart attack, stroke, and heart failure in type 2 diabetes patients. - Helps lower blood pressure by promoting weight loss and improving metabolic health. - Improves arterial function and lipid profiles, reducing bad cholesterol (LDL) and increasing good cholesterol (HDL). - Regular monitoring of blood pressure and cardiovascular health is advised, especially for patients with preexisting conditions. - Seek immediate medical attention if experiencing irregular heartbeat, dizziness, or swelling.

Storage

- Store unused pens in the refrigerator (2-8°C)—do not freeze. - Once opened, store at room temperature (below 30°C) or refrigerated for up to 30 days. - Protect from direct sunlight, moisture, and extreme temperatures. - Do not share injection pens, cartridges, or syringes, even if the needle is changed. - Keep out of reach of children and pets.

Possible Side Effects

Common side effects: - Nausea, vomiting, diarrhea (common in early use). - Reduced appetite, constipation, stomach discomfort. - Headache, fatigue, dizziness, or mild rash. Serious side effects (seek medical attention): - Severe abdominal pain (may indicate pancreatitis). - Signs of thyroid tumors (persistent hoarseness, difficulty swallowing, neck swelling). - Hypoglycemia (low blood sugar), especially if combined with insulin or sulfonylureas.

FAQs

Lirafit 6mg is a GLP-1 receptor agonist used for Type 2 diabetes management and weight loss. It stimulates insulin release, suppresses glucagon, and slows digestion to regulate blood sugar levels.
It contains Liraglutide, which enhances insulin secretion, reduces liver glucose production, and delays stomach emptying, helping with blood sugar control and appetite suppression.
While primarily prescribed for diabetes treatment, it is also used off-label for weight loss in individuals with obesity or metabolic disorders.
Store unused pens in the refrigerator (2-8°C). Once in use, keep at room temperature (below 30°C) or refrigerated for up to 30 days. Do not freeze.
Some users experience nausea, vomiting, diarrhea, reduced appetite, dizziness, and stomach discomfort. These usually improve over time.
Lirafit 6mg is not recommended for individuals with pancreatitis, thyroid cancer, or multiple endocrine neoplasia type 2 (MEN 2). Pregnant or breastfeeding women should consult a doctor.
Do not mix Lirafit with insulin in the same syringe. If using both, inject separately at different sites.
Take the missed dose as soon as possible within 12 hours. If more than 12 hours have passed, skip the dose and continue as scheduled.
Overdosing can cause severe nausea, vomiting, or hypoglycemia. Seek immediate medical attention if symptoms occur.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.